Quantification and reliability of [
Lungs
Muscarinic acetylcholine receptors
Positron emission tomography
Test-retest
[11C]VC-002
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
03 Jun 2020
03 Jun 2020
Historique:
received:
15
01
2020
accepted:
22
04
2020
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
5
6
2020
Statut:
epublish
Résumé
The radioligand [ PET measurements using [ The 1TCM was the statistically preferred model for description of [ The kinetic behaviour and good repeatability of [ ClinicalTrials.gov identifier: NCT03097380, registered: 31 March 2017.
Sections du résumé
BACKGROUND
BACKGROUND
The radioligand [
METHODS
METHODS
PET measurements using [
RESULTS
RESULTS
The 1TCM was the statistically preferred model for description of [
CONCLUSIONS
CONCLUSIONS
The kinetic behaviour and good repeatability of [
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov identifier: NCT03097380, registered: 31 March 2017.
Identifiants
pubmed: 32495011
doi: 10.1186/s13550-020-00634-0
pii: 10.1186/s13550-020-00634-0
pmc: PMC7270393
doi:
Banques de données
ClinicalTrials.gov
['NCT03097380']
Types de publication
Journal Article
Langues
eng
Pagination
59Références
Br J Pharmacol Chemother. 1965 Aug;25(1):4-17
pubmed: 19108209
J Nucl Med. 2007 Feb;48(2):207-13
pubmed: 17268016
J Manag Care Pharm. 2005 Jun;11(5 Suppl A):S2-13; quiz S14-6
pubmed: 15934804
J Cereb Blood Flow Metab. 2002 Oct;22(10):1271-81
pubmed: 12368666
J Nucl Med. 1999 Aug;40(8):1270-6
pubmed: 10450677
Pharmacol Rev. 2012 Jul;64(3):450-504
pubmed: 22611179
Trends Pharmacol Sci. 2006 Jun;27(6):310-6
pubmed: 16678917
EJNMMI Res. 2019 Jan 29;9(1):9
pubmed: 30694407
Acta Oncol. 2015;54(8):1105-12
pubmed: 25833329
Curr Radiopharm. 2020;13(3):185-194
pubmed: 31868150
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):301-7
pubmed: 24006152
Eur Respir J. 2003 Apr;21(4):567-73
pubmed: 12762337
J Cereb Blood Flow Metab. 1989 Oct;9(5):696-708
pubmed: 2528555
Am J Respir Crit Care Med. 2009 Sep 15;180(6):533-9
pubmed: 19574441
J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
pubmed: 8784228
Psychiatry Res. 1996 Oct 7;67(3):163-71
pubmed: 8912956
Clin Pharmacol Ther. 1995 Mar;57(3):309-17
pubmed: 7697948
Chest. 2005 Oct;128(4):3020-7
pubmed: 16236982
J Cereb Blood Flow Metab. 1996 Jan;16(1):42-52
pubmed: 8530554
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
J Nucl Med. 2000 Oct;41(10):1603-11
pubmed: 11037987
J Cereb Blood Flow Metab. 2000 Jul;20(7):1111-33
pubmed: 10908045
Eur J Nucl Med Mol Imaging. 2011 May;38(5):832-42
pubmed: 21210109
Am J Respir Crit Care Med. 1996 Nov;154(5):1277-83
pubmed: 8912736
EJNMMI Res. 2017 Dec;7(1):47
pubmed: 28547129
J Med Chem. 1997 Jan 3;40(1):117-24
pubmed: 9016336
Neuroimage. 2017 Jul 15;155:344-353
pubmed: 28419852
Clin Cancer Res. 2013 Jan 1;19(1):183-93
pubmed: 23136193
Respir Care. 2007 Jul;52(7):833-51
pubmed: 17594728
J Nucl Med. 2017 Feb;58(2):201-207
pubmed: 28082432
J Cereb Blood Flow Metab. 2002 Dec;22(12):1425-39
pubmed: 12468888
Am Rev Respir Dis. 1990 Jun;141(6):1559-68
pubmed: 2350099
Mol Pharmacol. 1966 Jul;2(4):352-9
pubmed: 5968075